Jimmy Van den Eynden

20PUBLICATIONS
51CO-AUTHORS
Cellular nervous systemInnate immunityMolecular targetsNeurogeneticsHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (20)

|Aug 08, 2025
Spatial transcriptomics exploration of the primary neuroblastoma microenvironment in archived FFPE samples unveils novel paracrine interactions.

Joachim T Siaw, Peter Merseburger, Marcus Borenäs

|Sep 30, 2024
MHC class II genotypes are independent predictors of anti-PD1 immunotherapy response in melanoma.

Arne Claeys, Jimmy Van den Eynden

|Jan 12, 2024
Preclinical exploration of the DNA damage response pathway using the interactive neuroblastoma cell line explorer CLEAN.

Jonatan L Gabre, Peter Merseburger, Arne Claeys

|Dec 28, 2023
ALK signaling primes the DNA damage response sensitizing ALK-driven neuroblastoma to therapeutic ATR inhibition.

Marcus Borenäs, Ganesh Umapathy, Dan E Lind

|Feb 15, 2023
ALK fusion NSCLC oncogenes promote survival and inhibit NK cell responses via SERPINB4 expression.

Tzu-Po Chuang, Wei-Yun Lai, Jonatan L Gabre

|Nov 25, 2021
ATR inhibition enables complete tumour regression in ALK-driven NB mouse models.

Joanna Szydzik, Dan E Lind, Badrul Arefin

Pageof 4

Frequent Collaborators

9 joint publications

Ruth H Palmer

8 joint publications

Bengt Hallberg

6 joint publications

Arne Claeys

4 joint publications

Jikui Guan